Renal Cancer - Results from #5400

Cytoreductive Surgery in the Management of Renal Tumours: Rationale, Current Evidence and Future Perspectives January 31, 2017

Magnetic Resonance Imaging and the Use in Small Renal Masses January 31, 2017

Prognostic Benefit of Surgical Management of Renal Cell Carcinoma Invading the Inferior Vena Cava January 31, 2017

[What can/should be treated in kidney tumors and when] January 30, 2017

Bullous Pemphigoid Associated with Nivolumab, a Programmed Cell Death 1 Protein Inhibitor January 30, 2017

Validation of preoperative variables and stratification of patients to help predict benefit of cytoreductive nephrectomy in the targeted therapy ERA January 30, 2017

Renal Masses Detected on FDG PET/CT in Patients With Lymphoma: Imaging Features Differentiating Primary Renal Cell Carcinomas From Renal Lymphomatous Involvement January 27, 2017

Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection January 27, 2017

Core Needle Biopsy and Fine Needle Aspiration Alone or in Combination: Diagnostic Accuracy and Impact on Management of Renal Masses January 27, 2017

The next 10 years: Challenges for the future and overcoming resistance to targeted therapies for renal cell carcinoma January 26, 2017

Practical first-line management of renal cell carcinoma in a community practice January 26, 2017

First-line treatment options in metastatic renal cell cancer January 26, 2017

Sunitinib side effects as surrogate biomarkers of efficacy January 26, 2017

The role of mTOR inhibition as second-line therapy in metastatic renal carcinoma: clinical evidence and current challenges January 25, 2017

Basic Parameters of Blood Count as Prognostic Factors for Renal Cell Carcinoma January 25, 2017

Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts January 25, 2017

Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinoma January 25, 2017

Targeting of Tumor Growth and Angiogenesis Underlies the Enhanced Antitumor Activity of Lenvatinib in Combination with Everolimus January 23, 2017

Incidence, clinicopathologic features, and fusion transcript landscape of translocation renal cell carcinomas January 23, 2017

Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review January 19, 2017

Page 271 of 458